VEGF signaling activates downstream pathways such as PI3K/Akt/mTOR and HIF-1α, which drive endothelial cell proliferation, migration, and survival, as well as upregulation of glycolytic enzymes like hexokinase 2, further supporting tumor metabolism and immune evasion [53]. This evidence concerns the gene MTOR and neoplasm.